stoxline Quote Chart Rank Option Currency Glossary
  
Cyanotech Corporation (CYAN)
0.4  0.03 (8.11%)    02-14 15:00
Open: 0.37
High: 0.4
Volume: 500
  
Pre. Close: 0.37
Low: 0.37
Market Cap: 3(M)
Technical analysis
2025-02-14 4:47:19 PM
Short term     
Mid term     
Targets 6-month :  0.45 1-year :  0.51
Resists First :  0.39 Second :  0.43
Pivot price 0.37
Supports First :  0.31 Second :  0.25
MAs MA(5) :  0.37 MA(20) :  0.36
MA(100) :  0.48 MA(250) :  0.45
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  33.3 D(3) :  40.7
RSI RSI(14): 49
52-week High :  0.88 Low :  0.11
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CYAN ] has closed above bottom band by 46.5%. Bollinger Bands are 34.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.37 - 0.37 0.37 - 0.37
Low: 0.36 - 0.37 0.37 - 0.37
Close: 0.37 - 0.37 0.37 - 0.37
Company Description

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

Headline News

Thu, 13 Feb 2025
Cyanotech Corp Reports Increased Sales Amid Continued Losses - TipRanks

Tue, 11 Feb 2025
Cyanotech Corporation (CYAN) reports earnings - Quartz

Tue, 11 Feb 2025
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025 - The Bakersfield Californian

Tue, 11 Feb 2025
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025 - Yahoo Finance

Tue, 11 Feb 2025
Cyanotech Delivers Strong Q3 Growth: Sales Surge 10.6% While Slashing Losses by 78% - StockTitan

Fri, 06 Sep 2024
Red Robin And 3 Other Stocks Under $5 Executives Are Buying - Nanophase Technologies (OTC:NANX) - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Consumer Defensive
Industry:
Packaged Foods
Shares Out 7 (M)
Shares Float 5 (M)
Held by Insiders 38 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 4 (K)
Stock Financials
EPS -0.76
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.52
Profit Margin -21.5 %
Operating Margin -17.7 %
Return on Assets (ttm) -9.9 %
Return on Equity (ttm) -39.7 %
Qtrly Rev. Growth 14.6 %
Gross Profit (p.s.) 0
Sales Per Share 3.36
EBITDA (p.s.) -0.38
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 3 (M)
Stock Valuations
PE Ratio -0.49
PEG Ratio 0
Price to Book value 0.24
Price to Sales 0.1
Price to Cash Flow 6.82
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android